Cargando…
Risk assessment regarding the use of Annona muricata in food supplements
The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (EU‐FORA) supported by EFSA and was intended to evaluate possible health risks associated with the consumption of Annona muricata L. (Annonaceae) and derived food supplements. A. murica...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691614/ https://www.ncbi.nlm.nih.gov/pubmed/33294051 http://dx.doi.org/10.2903/j.efsa.2020.e181112 |
_version_ | 1783614331584249856 |
---|---|
author | Raclariu‐Manolica, Ancuta Cristina Bakhiya, Nadiya Hirsch‐Ernst, Karen Ildico |
author_facet | Raclariu‐Manolica, Ancuta Cristina Bakhiya, Nadiya Hirsch‐Ernst, Karen Ildico |
collection | PubMed |
description | The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (EU‐FORA) supported by EFSA and was intended to evaluate possible health risks associated with the consumption of Annona muricata L. (Annonaceae) and derived food supplements. A. muricata grows as a tree and is native to the Caribbean and Central America. Preparations made from different plant parts of A. muricata (i.e. fruit, leaves, bark, roots) have been used as herbal medicine and are also marketed worldwide as over‐the‐counter food supplements that have been purported to support general health or to treat a wide range of health conditions, particularly cancer and parasitic infections. However, open questions remain regarding the safety of A. muricata‐based food supplements, since Annonaceae have been reported to contain potentially neurotoxic compounds, i.e. acetogenins. The assessment conducted within the present fellowship programme shows that substantial uncertainties exist regarding the safe use of A. muricata‐based supplements. The available data provide indications of neurotoxic potential of certain A. muricata preparations. The paucity of adequate studies, particularly related to long‐term use of A. muricata supplements, currently does not allow the establishment of a safe intake level. Within this technical report a workflow of the project is presented. |
format | Online Article Text |
id | pubmed-7691614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76916142020-12-07 Risk assessment regarding the use of Annona muricata in food supplements Raclariu‐Manolica, Ancuta Cristina Bakhiya, Nadiya Hirsch‐Ernst, Karen Ildico EFSA J EU‐FORA Series 3 The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (EU‐FORA) supported by EFSA and was intended to evaluate possible health risks associated with the consumption of Annona muricata L. (Annonaceae) and derived food supplements. A. muricata grows as a tree and is native to the Caribbean and Central America. Preparations made from different plant parts of A. muricata (i.e. fruit, leaves, bark, roots) have been used as herbal medicine and are also marketed worldwide as over‐the‐counter food supplements that have been purported to support general health or to treat a wide range of health conditions, particularly cancer and parasitic infections. However, open questions remain regarding the safety of A. muricata‐based food supplements, since Annonaceae have been reported to contain potentially neurotoxic compounds, i.e. acetogenins. The assessment conducted within the present fellowship programme shows that substantial uncertainties exist regarding the safe use of A. muricata‐based supplements. The available data provide indications of neurotoxic potential of certain A. muricata preparations. The paucity of adequate studies, particularly related to long‐term use of A. muricata supplements, currently does not allow the establishment of a safe intake level. Within this technical report a workflow of the project is presented. John Wiley and Sons Inc. 2020-11-26 /pmc/articles/PMC7691614/ /pubmed/33294051 http://dx.doi.org/10.2903/j.efsa.2020.e181112 Text en © 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | EU‐FORA Series 3 Raclariu‐Manolica, Ancuta Cristina Bakhiya, Nadiya Hirsch‐Ernst, Karen Ildico Risk assessment regarding the use of Annona muricata in food supplements |
title | Risk assessment regarding the use of Annona muricata in food supplements |
title_full | Risk assessment regarding the use of Annona muricata in food supplements |
title_fullStr | Risk assessment regarding the use of Annona muricata in food supplements |
title_full_unstemmed | Risk assessment regarding the use of Annona muricata in food supplements |
title_short | Risk assessment regarding the use of Annona muricata in food supplements |
title_sort | risk assessment regarding the use of annona muricata in food supplements |
topic | EU‐FORA Series 3 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691614/ https://www.ncbi.nlm.nih.gov/pubmed/33294051 http://dx.doi.org/10.2903/j.efsa.2020.e181112 |
work_keys_str_mv | AT riskassessmentregardingtheuseofannonamuricatainfoodsupplements AT raclariumanolicaancutacristina riskassessmentregardingtheuseofannonamuricatainfoodsupplements AT bakhiyanadiya riskassessmentregardingtheuseofannonamuricatainfoodsupplements AT hirschernstkarenildico riskassessmentregardingtheuseofannonamuricatainfoodsupplements |